Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects
This study has been completed.
Study NCT00829777   Information provided by California Pacific Medical Center Research Institute

First Received on January 23, 2009.   Last Updated on September 14, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Opiate Addiction
Additional conditions recognized in this trial
Behavior, Addictive
Opioid-Related Disorders
More general conditions related to this trial
Compulsive Behavior
Impulsive Behavior
Mental Disorders
Substance-Related Disorders
Additional drug interventions recognized in this trial
Analgesics, Opioid
Lactulose
Naloxone
More general drug interventions related to this trial
Analgesics
Central Nervous System Agents
Central Nervous System Depressants
Gastrointestinal Agents
Narcotic Antagonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
California Pacific Medical Center Research Institute


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services